David Stock

Post-Market Drug Evaluation Program, Canada’s Drug Agency (CDA), Canada

Poster(s):

• (C-069) Comparison of Expenditure and Utilization of Top 25 High-Cost Drugs Across Canada and Comparable Countries
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-068) Expenditure and Utilization on GLP-1 Medications across High-Income Countries: A repeated cross-sectional analysis
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-060) Opioid Agonist Treatment Dispensing Trends Between 2018 and 2022 Across Six Canadian Provinces
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET

• (C-092) Trends in opioid prescribing prior to opioid toxicity inpatient hospitalizations and ED visits in Canada, 2018-2022
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (C-102) Trends in prescription opioid use for pain in Canada: a population-based repeated cross-sectional study
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET